Status:
COMPLETED
Sevoflurane, Propofol, Postoperative Pain
Lead Sponsor:
Tampere University Hospital
Conditions:
Healthy Adults
Gynecological Disease
Eligibility:
FEMALE
18-69 years
Phase:
PHASE4
Brief Summary
The impact of anaesthetic method (intravenous vs. inhalational) has been proposed, but not proven in a large-scale study. The researchers aim to provide an investigation that has sufficient power to c...
Eligibility Criteria
Inclusion
- Age 18-69 years
- Gender: female
- ASA status 1-3
- Laparoscopic hysterectomy
Exclusion
- Body Mass Index over 35
- Diabetes mellitus
- Liver disease
- Allergies to pharmaceuticals used in the Study
- Present use of opioids
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT01437462
Start Date
October 1 2008
End Date
March 1 2013
Last Update
April 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33521